Trademark: 86942598
Word
OSE IMMUNOTHERAPEUTICS
Status Date
Tuesday, October 31, 2017
Registration Number
5320086
Registration Date
Tuesday, October 31, 2017
Filing Date
Wednesday, March 16, 2016
Published for Opposition
Tuesday, August 15, 2017
5 Pharmaceutical products in the nature of chemicals for cancer treatment, oncology and immunotherapy; sanitary preparations for medical purposes; pharmaceutical products for human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Substances for medicinal use, namely, synthetic peptides for cancer treatment, oncology and immunotherapy, adjuvants for medical purposes, stem cells for medical purposes; Vaccines for treating cancer; vaccines; Substances for medicinal use, namely, serums for cancer treatment, oncology and immunotherapy, monoclonal antibodies for cancers, auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, targeted therapies for cancers, auto immune diseases and biological tissue grafts or skin grafts
42 Scientific and technological services, namely, research and design services in the fields of cancer treatment, oncology, immunotherapy; design and development of software and databases; medical research; biological and biotechnology research; pharmaceutical research; conducting clinical studies for others
ORPHAN SYNERGY EUROPE IMMUNE THERAPEUTICS
"IMMUNOTHERAPEUTICS"
Oct 31, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 31, 2017
Registered-Principal Register
Aug 15, 2017
Official Gazette Publication Confirmation E-Mailed
Aug 15, 2017
Published For Opposition
Jul 26, 2017
Notification Of Notice Of Publication E-Mailed
Jul 6, 2017
Approved For Pub - Principal Register
Jun 8, 2017
Teas/Email Correspondence Entered
Jun 8, 2017
Correspondence Received In Law Office
Jun 2, 2017
Assigned To Lie
May 8, 2017
Teas Request For Reconsideration Received
May 8, 2017
Notification Of Final Refusal Emailed
May 8, 2017
Final Refusal E-Mailed
May 8, 2017
Final Refusal Written
Apr 10, 2017
Teas/Email Correspondence Entered
Apr 10, 2017
Correspondence Received In Law Office
Apr 10, 2017
Teas Response To Suspension Inquiry Received
Nov 25, 2016
Notification Of Letter Of Suspension E-Mailed
Nov 25, 2016
Letter Of Suspension E-Mailed
Nov 25, 2016
Suspension Letter Written
Oct 24, 2016
Teas/Email Correspondence Entered
Oct 24, 2016
Correspondence Received In Law Office
Oct 24, 2016
Teas Response To Office Action Received
Oct 20, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 20, 2016
Teas Change Of Owner Address Received
Aug 3, 2016
Automatic Update Of Assignment Of Ownership
Jul 6, 2016
Notification Of Non-Final Action E-Mailed
Jul 6, 2016
Non-Final Action E-Mailed
Jul 6, 2016
Non-Final Action Written
Jun 27, 2016
Assigned To Examiner
Mar 23, 2016
Teas Amendment Entered Before Attorney Assigned
Mar 23, 2016
Teas Voluntary Amendment Received
Mar 22, 2016
Notice Of Pseudo Mark E-Mailed
Mar 21, 2016
New Application Office Supplied Data Entered In Tram
Mar 19, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
